Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Endonovo Therapeutics Inc (PK) (ENDV)
Endonovo Therapeutics Inc (PK) (ENDV) Actualités

ENDV

Endonovo Therapeutics (PK) (ENDV)

Endonovo Therapeutics Inc (PK)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:ENDV

1

Date	Heure	Source	Titre	Symbole	Société
02/02/2024	23h23	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
03/01/2024	23h30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
29/12/2023	21h20	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
15/11/2023	18h21	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
25/08/2023	13h04	Edgar (US Regulatory)	Form 1-A/A - Offering Statement [Regulation A]: [Amend]	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
21/08/2023	23h16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
14/06/2023	20h27	Edgar (US Regulatory)	Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
16/05/2023	12h02	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
17/04/2023	22h39	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
31/03/2023	21h55	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
29/03/2023	13h01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
22/08/2022	15h14	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
16/07/2020	17h35	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
10/07/2020	22h32	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
07/07/2020	19h47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
23/06/2020	22h02	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
09/06/2020	12h01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
02/06/2020	13h59	Edgar (US Regulatory)	Withdrawal of a Registration Statement Withdrawal Request (rw Wd)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
02/06/2020	12h07	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)
29/05/2020	23h32	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:ENDV	Endonovo Therapeutics Inc (PK)

Showing the most relevant articles for your search:USOTC:ENDV

1

JP Morgan Chase

Credit Agricole

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales